Type 2 immune response

pathway activity — cross-omics
GO:0042092Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Type 2 immune response pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are DIPK1A, EXTL2, and CALHM5, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Type 2 immune response activity versus DIPK1A in BRCA (Pearson r = -0.15).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCADIPK1A →-0.696-0.697.003<.00134
BRCAEXTL2 →-0.492-0.491.001.00234
HNSCCALHM5 →-0.737-0.535<.001<.00134
HNSCINHBA →-0.787-0.344.008.00734
LSCCCDH11 →-0.590-0.503.006.00534
LUADHCFC1R1 →-0.361-0.400<.001<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0042092 vs DIPK1A — BRCA

Per-sample scatter of Type 2 immune response activity vs DIPK1A in BRCA.

Explore this scatter interactively →

Exploration